During the past decade, MEDICENTRUM 6 s.r.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MEDICENTRUM 6 s.r.o." are "Meningococcal Vaccine" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "MEDICENTRUM 6 s.r.o." in a lesser frequency.

Most popular intervention types in "MEDICENTRUM 6 s.r.o." are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "MenABCWY" (1 trials), "MenACWY-CRM" (1 trials) and "Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "MEDICENTRUM 6 s.r.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "MEDICENTRUM 6 s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MEDICENTRUM 6 s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MEDICENTRUM 6 s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".